Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.

Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...

Bitcoin Is Bouncing but Ether Is Soaring. This Is Why.

Text size Cryptocurrencies are gaining as investors return to high-growth “risk assets.” Dreamstime Bitcoin has perked up, gaining 8% to roughly $42,600 in the past week. But Ether, the se...